InfuSystem Holdings Inc
F:1TZ
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
I
|
InfuSystem Holdings Inc
AMEX:INFU
|
150.3m USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
100B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
77.8B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
65.9B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.4B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.7B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.5B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23.3B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.7B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.8B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
InfuSystem Holdings Inc
Glance View
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 420 full-time employees. The company went IPO on 2006-06-15. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for InfuSystem Holdings Inc is 54.5%, which is above its 3-year median of 52.3%.
Over the last 3 years, InfuSystem Holdings Inc’s Gross Margin has decreased from 56.9% to 54.5%. During this period, it reached a low of 49.7% on Jun 30, 2024 and a high of 57.4% on Sep 30, 2022.
